Page 86 - Micron News Today

Sir John Bell, an immunologist who was a member of the UK Covid Vaccine Taskforce and former government chief scientific adviser, warned last month that Britain is now no more prepared for a new novel pandemic than it was for COVID-19.

Researchers characterized the children with severe acute respiratory syndrome coronavirus 2 reinfection.

Researchers tested the seroprevalence against SARS-CoV-2 in pet cats in the U.K.

SK hynix posted an operating loss of 3.4 trillion won ($2.54 billion) in the first quarter of this year, suffering a loss for the second consecutive quarter due to deteriorating semiconductor industry conditions, the memory chipmaker said, Wednesday. However, the company added it expects global chip market conditions to recover in the second quarter after bottoming out in the first three months of this year.

The World Health Organization recently named the SARS-CoV-2 Omicron variant XBB1.16 a variant of interest to encourage tracking of this genetic variant of the pandemic coronavirus.

Research reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years. The study found that the vaccine was safe, immunogenic, and efficacious in preventing COVID-19, including the Delta variant, in adolescents.

Proven Regional Leaders Melanie Littlejohn and Tim Penix to Helm the Micron Community Engagement Committee as Co-Chairs Committee will Develop a Community Priorities Document to Guide Strategies in... | April 28, 2023

Micron Technology has recently notified its distributors that starting in May, it will not consider any requests for DRAM and NAND flash quotes lower than the current levels, according to market sources.

Previously, it was rumored that the US had requested South Korea to not fill in the demand gap left behind after Micron got sanctioned by China. Samsung Electronics and SK Hynix are once again caught up in the tussle between China and the US. Whether this issue will be brought up for negotiation during the Korean-US summit is also a point of concern.

MyJournals.org - Science - Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO) (BMC Infectious Diseases)